Document is current
Any future updates will be listed below
-
Authors
Bitker, Laurent https://orcid.org/0000-0002-4698-053X
Dupuis, Claire
Pradat, Pierre
Deniel, Guillaume
Klouche, Kada
Mezidi, Mehdi
Chauvelot, Louis
Yonis, Hodane
Baboi, Loredana
Illinger, Julien
Souweine, Bertrand
Richard, Jean-Christophe
-
Funding
Funding for this research was provided by:
Direction Générale de l’offre de Soins (Programme Hospitalier de Recherche Clinique Inter-régional (PHRC-I) 2019)
Hospices Civils de Lyon
- License Information
-
More Information
Article History
Received: 4 July 2024
Accepted: 29 September 2024
First Online: 17 October 2024
Declarations
:
: LB is the recipient of the study’s funding grant from the Programme Hospitalier de Recherche Clinique Inter-régional (PHRC-I 2019) from the Direction Générale de l’Offre de Soin (French Ministry of Health). JI declares registration and travel fees for congress attendance payed by Pfizer. J-CR declares registration and travel fees for congress attendance payed by Pfizer. All other authors declare no competing interests.
: The study was conducted in accordance with the Declaration of Helsinki and with local regulations. The study was registered at ClinicalTrials.gov (NCT04801784) before the first patient was enrolled. The study protocol was reviewed and approved by an ethics committee for human research (Comité de Protection des Personnes Sud Méditerranée I, IDCRB 2021-A00692-39).
